Longitudinal changes in DNA methylation associated with clozapine use in treatment-resistant schizophrenia from two international cohorts
The second-generation antipsychotic clozapine is used as a medication for treatment-resistant schizophrenia. It has previously been associated with epigenetic changes in pre-clinical rodent models and cross-sectional studies of treatment-resistant schizophrenia. Cross-sectional studies are susceptib...
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Springer Nature [academic journals on nature.com]
2024
|
| _version_ | 1826314650035159040 |
|---|---|
| author | Gillespie, AL Walker, EM Hannon, E McQueen, GA Sendt, K Avila, A Lally, J Okhuijsen-Pfeifer, C van der Horst, M Hasan, A Dempster, EL Burrage, J Bogers, J Cohen, D Boks, MP Collier, DA Egerton, A Luykx, JJ Mill, J MacCabe, JH |
| author_facet | Gillespie, AL Walker, EM Hannon, E McQueen, GA Sendt, K Avila, A Lally, J Okhuijsen-Pfeifer, C van der Horst, M Hasan, A Dempster, EL Burrage, J Bogers, J Cohen, D Boks, MP Collier, DA Egerton, A Luykx, JJ Mill, J MacCabe, JH |
| author_sort | Gillespie, AL |
| collection | OXFORD |
| description | The second-generation antipsychotic clozapine is used as a medication for treatment-resistant schizophrenia. It has previously been associated with epigenetic changes in pre-clinical rodent models and cross-sectional studies of treatment-resistant schizophrenia. Cross-sectional studies are susceptible to confounding, however, and cannot disentangle the effects of diagnosis and medication. We therefore profiled DNA methylation in sequential blood samples (n = 126) from two independent cohorts of patients (n = 38) with treatment-resistant schizophrenia spectrum disorders who commenced clozapine after study enrolment and were followed up for up to six months. We identified significant non-linear changes in cell-type proportion estimates derived from DNA methylation data - specifically B-cells - associated with time on clozapine. Mixed effects regression models were used to identify changes in DNA methylation at specific sites associated with time on clozapine, identifying 37 differentially methylated positions (DMPs) (p < 5 × 10-5) in a linear model and 90 DMPs in a non-linear quadratic model. We compared these results to data from our previous epigenome-wide association study (EWAS) meta-analysis of psychosis, finding evidence that many previously identified DMPs associated with schizophrenia and treatment-resistant schizophrenia might reflect exposure to clozapine. In conclusion, our results indicate that clozapine exposure is associated with changes in DNA methylation and cellular composition. Our study shows that medication effects might confound many case-control studies of neuropsychiatric disorders performed in blood. |
| first_indexed | 2024-12-09T03:10:29Z |
| format | Journal article |
| id | oxford-uuid:d747b13e-75d8-4785-8f4f-85fafd172588 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-12-09T03:10:29Z |
| publishDate | 2024 |
| publisher | Springer Nature [academic journals on nature.com] |
| record_format | dspace |
| spelling | oxford-uuid:d747b13e-75d8-4785-8f4f-85fafd1725882024-09-28T20:07:50ZLongitudinal changes in DNA methylation associated with clozapine use in treatment-resistant schizophrenia from two international cohortsJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:d747b13e-75d8-4785-8f4f-85fafd172588EnglishJisc Publications RouterSpringer Nature [academic journals on nature.com]2024Gillespie, ALWalker, EMHannon, EMcQueen, GASendt, KAvila, ALally, JOkhuijsen-Pfeifer, Cvan der Horst, MHasan, ADempster, ELBurrage, JBogers, JCohen, DBoks, MPCollier, DAEgerton, ALuykx, JJMill, JMacCabe, JHThe second-generation antipsychotic clozapine is used as a medication for treatment-resistant schizophrenia. It has previously been associated with epigenetic changes in pre-clinical rodent models and cross-sectional studies of treatment-resistant schizophrenia. Cross-sectional studies are susceptible to confounding, however, and cannot disentangle the effects of diagnosis and medication. We therefore profiled DNA methylation in sequential blood samples (n = 126) from two independent cohorts of patients (n = 38) with treatment-resistant schizophrenia spectrum disorders who commenced clozapine after study enrolment and were followed up for up to six months. We identified significant non-linear changes in cell-type proportion estimates derived from DNA methylation data - specifically B-cells - associated with time on clozapine. Mixed effects regression models were used to identify changes in DNA methylation at specific sites associated with time on clozapine, identifying 37 differentially methylated positions (DMPs) (p < 5 × 10-5) in a linear model and 90 DMPs in a non-linear quadratic model. We compared these results to data from our previous epigenome-wide association study (EWAS) meta-analysis of psychosis, finding evidence that many previously identified DMPs associated with schizophrenia and treatment-resistant schizophrenia might reflect exposure to clozapine. In conclusion, our results indicate that clozapine exposure is associated with changes in DNA methylation and cellular composition. Our study shows that medication effects might confound many case-control studies of neuropsychiatric disorders performed in blood. |
| spellingShingle | Gillespie, AL Walker, EM Hannon, E McQueen, GA Sendt, K Avila, A Lally, J Okhuijsen-Pfeifer, C van der Horst, M Hasan, A Dempster, EL Burrage, J Bogers, J Cohen, D Boks, MP Collier, DA Egerton, A Luykx, JJ Mill, J MacCabe, JH Longitudinal changes in DNA methylation associated with clozapine use in treatment-resistant schizophrenia from two international cohorts |
| title | Longitudinal changes in DNA methylation associated with clozapine use in treatment-resistant schizophrenia from two international cohorts |
| title_full | Longitudinal changes in DNA methylation associated with clozapine use in treatment-resistant schizophrenia from two international cohorts |
| title_fullStr | Longitudinal changes in DNA methylation associated with clozapine use in treatment-resistant schizophrenia from two international cohorts |
| title_full_unstemmed | Longitudinal changes in DNA methylation associated with clozapine use in treatment-resistant schizophrenia from two international cohorts |
| title_short | Longitudinal changes in DNA methylation associated with clozapine use in treatment-resistant schizophrenia from two international cohorts |
| title_sort | longitudinal changes in dna methylation associated with clozapine use in treatment resistant schizophrenia from two international cohorts |
| work_keys_str_mv | AT gillespieal longitudinalchangesindnamethylationassociatedwithclozapineuseintreatmentresistantschizophreniafromtwointernationalcohorts AT walkerem longitudinalchangesindnamethylationassociatedwithclozapineuseintreatmentresistantschizophreniafromtwointernationalcohorts AT hannone longitudinalchangesindnamethylationassociatedwithclozapineuseintreatmentresistantschizophreniafromtwointernationalcohorts AT mcqueenga longitudinalchangesindnamethylationassociatedwithclozapineuseintreatmentresistantschizophreniafromtwointernationalcohorts AT sendtk longitudinalchangesindnamethylationassociatedwithclozapineuseintreatmentresistantschizophreniafromtwointernationalcohorts AT avilaa longitudinalchangesindnamethylationassociatedwithclozapineuseintreatmentresistantschizophreniafromtwointernationalcohorts AT lallyj longitudinalchangesindnamethylationassociatedwithclozapineuseintreatmentresistantschizophreniafromtwointernationalcohorts AT okhuijsenpfeiferc longitudinalchangesindnamethylationassociatedwithclozapineuseintreatmentresistantschizophreniafromtwointernationalcohorts AT vanderhorstm longitudinalchangesindnamethylationassociatedwithclozapineuseintreatmentresistantschizophreniafromtwointernationalcohorts AT hasana longitudinalchangesindnamethylationassociatedwithclozapineuseintreatmentresistantschizophreniafromtwointernationalcohorts AT dempsterel longitudinalchangesindnamethylationassociatedwithclozapineuseintreatmentresistantschizophreniafromtwointernationalcohorts AT burragej longitudinalchangesindnamethylationassociatedwithclozapineuseintreatmentresistantschizophreniafromtwointernationalcohorts AT bogersj longitudinalchangesindnamethylationassociatedwithclozapineuseintreatmentresistantschizophreniafromtwointernationalcohorts AT cohend longitudinalchangesindnamethylationassociatedwithclozapineuseintreatmentresistantschizophreniafromtwointernationalcohorts AT boksmp longitudinalchangesindnamethylationassociatedwithclozapineuseintreatmentresistantschizophreniafromtwointernationalcohorts AT collierda longitudinalchangesindnamethylationassociatedwithclozapineuseintreatmentresistantschizophreniafromtwointernationalcohorts AT egertona longitudinalchangesindnamethylationassociatedwithclozapineuseintreatmentresistantschizophreniafromtwointernationalcohorts AT luykxjj longitudinalchangesindnamethylationassociatedwithclozapineuseintreatmentresistantschizophreniafromtwointernationalcohorts AT millj longitudinalchangesindnamethylationassociatedwithclozapineuseintreatmentresistantschizophreniafromtwointernationalcohorts AT maccabejh longitudinalchangesindnamethylationassociatedwithclozapineuseintreatmentresistantschizophreniafromtwointernationalcohorts |